HYDROMORPHONE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]

HYDROMORPHONE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]
PDF | XML

NDC	52533-005-45
Set ID	a5d20cb8-5e51-4149-a5c9-d0b016c13e05
Category	HUMAN PRESCRIPTION DRUG LABEL
Packager	Cantrell Drug Company
Generic Name
Product Class
Product Number
Application Number

View All Sections

PRINCIPAL DISPLAY PANEL
SPL UNCLASSIFIED SECTION

INGREDIENTS AND APPEARANCE

HYDROMORPHONE HCL
hydromorphone hcl injection, solution

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC:52533-005
Route of Administration	INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS	DEA Schedule	CII

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
HYDROMORPHONE HYDROCHLORIDE (UNII: L960UP2KRW) (HYDROMORPHONE - UNII:Q812464R06)	HYDROMORPHONE HYDROCHLORIDE	0.5 mg in 1 mL

Ingredient Name	Strength
Inactive Ingredients
Sodium Chloride (UNII: 451W47IQ8X)	9 mg in 1 mL
WATER (UNII: 059QF0KO0R)

Ingredient Kind	Ingredient Name	Quantity
Other Ingredients
May contain	HYDROCHLORIC ACID (UNII: QTT17582CB)
May contain	SODIUM HYDROXIDE (UNII: 55X04QC32I)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:52533-005-45	1 mL in 1 SYRINGE, PLASTIC

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved drug other		10/11/2013

Labeler - Cantrell Drug Company (035545763)

View All Sections

Related Drugs